Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results but remains strong in diabetes treatment, insulin, and GLP-1 products. I outline the bull case ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has soared some 40 per cent over the last year as investors celebrated its ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Based on SOUL findings, Novo Nordisk submitted a label extension application for Rybelsus ® for CV event risk reduction to the US FDA and EMA. The SOUL trial achieved its primary endpoint ...

March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...

The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...

German software company SAP overtook Danish healthcare company Novo Nordisk as Europe’s largest company by market capitalisation on Monday. At 0900 GMT, SAP had a market cap of $340 billion, slightly ...

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called ...

Patients can purchase a month’s supply for a $499 cash payment. Originally, this reduced price was only available through Novo Nordisk’s DTC pharmacy. Now, the company is expanding that discount to ...

SAP SAP has overtaken Danish pharmaceutical group Novo Nordisk NOVO B to become Europe’s most valuable publicly listed company amid renewed investor confidence in European stocks. With a market ...

We’ve known since the 1980s that unfiltered coffee is more likely to raise “bad” cholesterol levels compared to filtered coffee, instant coffee and coffee pods. High LDL cholesterol is a ...